Skip to main content
Gilberto Lopes Jr, MD, Oncology, Miami, FL

GilbertoDe LimaLopesJrMD

Oncology Miami, FL

Gastrointestinal Cancer, Thoracic Cancer

Physician

Dr. Lopes is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lopes' full profile

Already have an account?

  • Office

    1475 NW 12th Ave
    Miami, FL 33136
    Phone+1 305-243-1000
    Fax+1 305-689-4673

Summary

  • https://touch.www.linkedin.com/?sessionid=16989001089024&as=false&rs=false&can=https%3A%2F%2Fwww%2Elinkedin%2Ecom%2Fin%2Fdrgilbertolopes&dl=no#profile/url=https%3A%2F%2Fwww%2Elinkedin%2Ecom%2Fin%2Fdrgilbertolopes

Education & Training

  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2003 - 2006
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemResidency, Internal Medicine, 1999 - 2003
  • Federal University of Rio Grande do Sul School of Medicine
    Federal University of Rio Grande do Sul School of MedicineClass of 1997
  • Bradford University
    Bradford UniversityMBA, business and economics of cancer care, with merit
  • Lee Kwan Yew School of Public Policy
    Lee Kwan Yew School of Public Policycertificate on health care management and policy

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2002 - 2025
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Access to New and Expensive Medications in Developing Countries 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018

Press Mentions

  • The SKIPPirr Study: Dr. Spira Shares Insights at IASLC 2024 World Conference on Lung Cancer
    The SKIPPirr Study: Dr. Spira Shares Insights at IASLC 2024 World Conference on Lung CancerSeptember 12th, 2024
  • Dexamethasone Reduces Infusion-Related Reactions in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Treated with Intravenous RYBREVANT® (Amivantamab-Vmjw)
    Dexamethasone Reduces Infusion-Related Reactions in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Treated with Intravenous RYBREVANT® (Amivantamab-Vmjw)September 10th, 2024
  • Drug Pricing Strategies to Reduce the Financial Burden of Immunotherapy
    Drug Pricing Strategies to Reduce the Financial Burden of ImmunotherapyMay 31st, 2024
  • Join now to see all